Clinical trials: Resectable Pancreatic Cancers
Pancreas Cancer, Cancer
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
This is a Phase I evaluation to determine the usefulness of a new brachytherapy device that utilizes active components (Palladium-103) of standard devices in a novel configuration.
- Trial name
- NCT03109041
- Testing
- CivaSheet
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- CivaTech Oncology
Pancreatic Cancer, Pancreatic Carcinoma Non-resectable
Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
Unfortunately, despite the best clinical efforts and breakthroughs in biotechnology, most patients diagnosed with pancreatic cancer continue to die from the rapid progression of their disease.
- Trial name
- NCT02405585
- Testing
- mFOLFIRINOX, Algenpantucel-L Immunotherapy, SBRT
- Where
- 4 sites in United States
- Volunteers
- 10 people
- Sponsor
- NewLink Genetics Corporation